Clinical Research Directory
Browse clinical research sites, groups, and studies.
Optimized Cardiopulmonary Bypass Flow Strategy Based on Ideal Body Weight in Obese Patients Undergoing Cardiac Surgery
Sponsor: Centre Hospitalier Universitaire, Amiens
Summary
Cardiopulmonary bypass (CPB) pump flow is typically calculated according to body surface area (BSA) derived from actual body weight and temperature, following the 2024 European guidelines recommending an indexed flow of 2.4 L/min/m². However, in obese patients, using actual weight leads to a high BSA and thus elevated pump flow, increasing technical challenges such as the need for larger cannulas, higher circulating blood volume, and elevated pump speeds. These adjustments may increase risks of hemodilution, transfusion, and hemolysis. Given that lean body mass in obese patients is similar to that of non-obese patients of the same height-and that aerobic metabolism depends on lean mass-adjusting CPB flow based on ideal body weight rather than actual weight could reduce transfusions and associated complications. Several observational studies support the concept of using ideal body weight for CPB flow calculation in obese patients. Despite this, no randomized controlled trial has yet addressed the clinical impact of this approach. Given the increasing prevalence of obesity and the practical challenges it poses during cardiac surgery, a controlled clinical trial is warranted. The investigators hypothesize that adjusting the cardiopulmonary bypass (CPB) flow according to the ideal body weight rather than the actual body weight in obese patients could reduce the need for blood transfusions and limit the associated complications.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
184
Start Date
2026-09-21
Completion Date
2029-09
Last Updated
2026-11-04
Healthy Volunteers
No
Conditions
Interventions
cardiopulmonary bypas
CPB is standardized according to the following protocol: * Cardiac index at 2.4 ml/min/m² * Mean arterial pressure during CPB between 50 and 80 mm Hg * Central venous oxygen saturation \> 65% * Hematocrit \> 25% * DO₂ \> 280 ml/min/m² * VCO₂/DO₂ \> 6 (VCO₂: CO₂ production) CPB will be performed under normothermia, with a temperature \> 36°C.
Anticoagulation
Anticoagulation will be managed according to center practices to maintain an activated clotting time (ACT) \> 400 seconds, in accordance with recommendations.
Locations (1)
CHU Amiens Picardie
Amiens, France